home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 12/05/23

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials

FREMONT, CA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (“ABVC” or the “Company”) (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and op...
ABVC - 24/7 Market News Snapshot 22 Nov 2023

2023-11-22 09:57:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ESGL Holdings Ltd (NASDAQ: ESGL), SciSparc Ltd (NASDAQ: SPRC), Safety Shot Inc (NASDAQ: SHOT), PaxMedica Inc ...

ABVC - 24/7 Market News Snapshot 21 Nov 2023

2023-11-21 10:05:00 ET DENVER, Colo., Nov. 21, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Anghami Inc (NASDAQ: ANGH), ABVC BioPharma Inc (NASDAQ: ABVC), Can Fite Biofarma Ltd (AMEX: CANF), Altamira T...

ABVC - LogicMark, Morphosys AG among healthcare movers

2023-11-21 09:59:42 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
ABVC - ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

FREMONT, CA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that it received a ...

ABVC - ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M

FREMONT, CA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced...

ABVC - ABVC BioPharma GAAP EPS of -$0.82, revenue of $0.02M

2023-11-15 10:34:43 ET More on ABVC BioPharma ABVC shares jump after signing licensing deal for CNS drugs ABVC looks to establish a healthcare center, buys 20% stake in real estate property Financial information for ABVC BioPharma For further details see: ...
ABVC - ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results

FREMONT, CA - ( NewMediaWire ) - November 15, 2023 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"):   Today, a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes announced its financ...

ABVC - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

ABVC - Expected earnings - ABVC BioPharma Inc.

ABVC BioPharma Inc. (ABVC) is expected to report for Q3 2023
Previous 10 Next 10